FDA Inspection 1094745 — Jiangsu Hansoh Pharmaceutical Group Co., Ltd
The FDA completed an inspection of Jiangsu Hansoh Pharmaceutical Group Co., Ltd on Jun 13, 2019 in Lianyungang. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jun 13, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Lianyungang (China)